Cost and access barriers are pushing people to modified use and unapproved versions.
Millions in US use unapproved GLP-1s—and use them in unapproved ways
In short
Severe financial obstacles and limited access are driving millions of Americans toward alternative GLP-1 treatments. Faced with these steep barriers, patients are actively resorting to modified usage habits rather than following standard regimens. Consequently, many individuals are turning directly to unapproved versions of these medications to fulfill their personal health needs.
Key points
- Systemic financial hurdles are pushing a significant patient population toward non-standa…: Systemic financial hurdles are pushing a significant patient population toward non-standard medical options.
- Restricted access directly influences how millions of Americans choose to administer thei…: Restricted access directly influences how millions of Americans choose to administer their medications.
- Affordability challenges remain a major driving factor behind the use of unapproved pharm…: Affordability challenges remain a major driving factor behind the use of unapproved pharmaceutical alternatives.